Pharmacokinetics of edoxaban in EGFR-mutated non-small cell lung cancer patients with venous thromboembolism

2020 ◽  
Author(s):  
Takamasa Hotta ◽  
Yukari Tsubata ◽  
Kosuke Hamai ◽  
Akari Tanino ◽  
Misato Kobayashi ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Venous Thromboembolism ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Lung Cancer Patients ◽  
Egfr Mutated

PO-16 Venous thromboembolism in small cell lung cancer patients: an epidemiological study

2021 ◽  
Vol 200 ◽  
pp. S25-S26
Author(s):  
E. Dimakakos ◽  
K. Livanios ◽  
E. Kainis ◽  
A. Vassias ◽  
D. Stefanou ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Venous Thromboembolism ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Epidemiological Study ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Lung Cancer Patients

scholarly journals EGFR mutated non-small cell lung cancer patients: More prone to development of bone and brain metastases?

Lung Cancer ◽  
2014 ◽  
Vol 84 (1) ◽  
pp. 86-91 ◽  
Author(s):  
L.E.L. Hendriks ◽  
E.F. Smit ◽  
B.A.H. Vosse ◽  
W.W. Mellema ◽  
D.A.M. Heideman ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Brain Metastases ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Lung Cancer Patients ◽  
Egfr Mutated
Sign in / Sign up

Export Citation Format

Share Document